Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.540 -0.010 (-0.65%)
Streaming Delayed Price Updated: 3:08 PM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,337
Open 1.555
Bid (Size) 1.530 (200)
Ask (Size) 1.550 (200)
Prev. Close 1.550
Today's Range 1.510 - 1.555
52wk Range 0.5750 - 3.350
Shares Outstanding 9,377,034
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), today announce that... 
Via Newsfile
News headline image
Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+37.5%
+37.5%
1 Month
-1.3%
-1.3%
3 Month
+138.8%
+138.8%
6 Month
+40.0%
+40.0%
1 Year
-52.6%
-52.6%

More News

Read More
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Taylor Morrison Home Corporation (NYSE - TMHC), Rallybio Corporation (Nasdaq – RLYB), InMed Pharmaceuticals, Inc. (Nasdaq – INM), KalVista Pharmaceuticals, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether RAMP, NEE, INM, D are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether D, AVB, INM, EQR are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether SEM, WSR, INM, GDOT are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
InMed Pharmaceuticals Amends Preferred Investment Options
Via Newsfile
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
What's Driving InMed's (INM) 22% After-Hours Surge? ↗
Via Benzinga
News headline image
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Science Virtual Investor Forum Agenda Announced for September 18th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Via Chartmill
News headline image
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data ↗
Via Benzinga
News headline image
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Via Newsfile
Topics Regulatory Compliance
News headline image
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Via Newsfile
Topics Regulatory Compliance
News headline image
Here are the top movers in Tuesday's session. ↗
Via Chartmill
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
Via Investor Brand Network
News headline image
Curious about the most active stocks on Tuesday? ↗
Via Chartmill

Frequently Asked Questions

Is InMed Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, InMed Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does InMed Pharmaceuticals Inc. - Common Shares trade on?
InMed Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for InMed Pharmaceuticals Inc. - Common Shares?
The ticker symbol for InMed Pharmaceuticals Inc. - Common Shares is INM on the Nasdaq Stock Market
What is the current price of InMed Pharmaceuticals Inc. - Common Shares?
The current price of InMed Pharmaceuticals Inc. - Common Shares is 1.540
When was InMed Pharmaceuticals Inc. - Common Shares last traded?
The last trade of InMed Pharmaceuticals Inc. - Common Shares was at 07/01/26 03:08 PM ET
What is the market capitalization of InMed Pharmaceuticals Inc. - Common Shares?
The market capitalization of InMed Pharmaceuticals Inc. - Common Shares is 14.44M
How many shares of InMed Pharmaceuticals Inc. - Common Shares are outstanding?
InMed Pharmaceuticals Inc. - Common Shares has 14M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.